From purchase to patient: Geisinger’s AI-powered approach to drug diversion prevention
Barbara Zirnhelt
Drug diversion continues to pose a significant and persistent challenge for healthcare systems across the country. Even with strict adherence to professional standards and regulatory requirements, many organizations still lack a fully integrated, systemwide approach to effectively reduce the risks associated with controlled substances. At Geisinger, we have
